Daegu, South Korea

Yi Kyung Ko

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 12.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Daegu, KR (2019 - 2022)
  • Incheon, KR (2022)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Yi Kyung Ko in Cancer Research**

Introduction

Yi Kyung Ko, a prominent inventor located in Daegu, South Korea, has made significant strides in the field of pharmaceutical research, particularly in cancer treatment. With a portfolio of eight patents, Ko's work exemplifies the intersection of scientific inquiry and practical application in medicine.

Latest Patents

Ko's most recent patents include innovative compounds such as a heteroaryl derivative, specifically a 6-(isooxazolidin-2-yl)-N-phenylpyrimidin-4-amine derivative. This compound has been formulated into a pharmaceutical composition aimed at preventing or treating cancer. It demonstrates high inhibitory activity against various epidermal growth factor receptor (EGFR) variants, as well as ERBB2 and ERBB4, making it a valuable tool for targeting cancers where these receptors are expressed. Notably, the compound shows exceptional efficacy in inhibiting the proliferation of lung cancer cell lines, underscoring its potential use in lung cancer therapies.

Career Highlights

Throughout his career, Yi Kyung Ko has contributed to the advancement of medical innovation while working with esteemed organizations such as the Daegu-Gyeongbuk Medical Innovation Foundation and Voronoi Inc. His role in these institutions has enabled him to push the boundaries of research in pharmaceuticals and gain recognition within the scientific community.

Collaborations

Ko's work has been enriched by collaborations with other talented professionals in his field. Noteworthy colleagues include Hwan Geun Choi and the accomplished woman inventor Jung Beom Son. These partnerships highlight the collaborative nature of scientific research, leading to breakthroughs in innovative healthcare solutions.

Conclusion

Yi Kyung Ko continues to be a pivotal figure in the realm of pharmaceutical innovations, particularly in the fight against cancer. His patents reflect not only his creativity and ingenuity as an inventor but also his commitment to improving patient outcomes through advanced therapeutic options. As research progresses, Ko's contributions will undoubtedly pave the way for new and effective treatments in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…